about
Exploring preferences for symptom management in primary care: a discrete choice experiment using a questionnaire survey.Managing Minor Ailments; The Public's Preferences for Attributes of Community Pharmacies. A Discrete Choice ExperimentMen's preferences for the treatment of lower urinary tract symptoms associated with benign prostatic hyperplasia: a discrete choice experiment.Decision heuristic or preference? Attribute non-attendance in discrete choice problems.What do UK medical students value most in their careers? A discrete choice experiment.Patients' preferences for anti-osteoporosis drug treatment: a cross-European discrete choice experiment.Is Best-Worst Scaling Suitable for Health State Valuation? A Comparison with Discrete Choice Experiments.A generation of childless women: lessons from the United States."Doctor my eyes": A natural experiment on the demand for eye care services.Economic considerations and patients' preferences affect treatment selection for patients with rheumatoid arthritis: a discrete choice experiment among European rheumatologists.Does one size fit all? Investigating heterogeneity in men's preferences for benign prostatic hyperplasia treatment using mixed logit analysis.Utilisation of eye-care services: the effect of Scotland's free eye examination policy.Discrete Choice Experiment Response Rates: A Meta-analysis.Re-Thinking 'The Different Perspectives That can be Used When Eliciting Preferences in Health'.The Best of Both Worlds: An Example Mixed Methods Approach to Understand Men's Preferences for the Treatment of Lower Urinary Tract Symptoms.Evaluation of patients' preferences for genital herpes treatment.Rationalising the 'irrational': a think aloud study of discrete choice experiment responses."Choice" and place of delivery: a qualitative study of women in remote and rural ScotlandModels of intrapartum care and women’s trade-offs in remote and rural Scotland: a mixed-methods studyTask complexity and response certainty in discrete choice experiments: An application to drug treatments for juvenile idiopathic arthritisExploring preference anomalies in double bounded contingent valuationRapid prenatal diagnostic testing for Down syndrome only or longer wait for full karyotype: the views of pregnant womenInvolving the public in priority setting: a case study using discrete choice experimentsWhat do UK doctors in training value in a post? A discrete choice experimentComment on: Patients' preferences for anti-osteoporosis drug treatment: a cross-European discrete choice experiment: replyMode and Frame Matter: Assessing the Impact of Survey Mode and Sample Frame in Choice Experiments
P50
Q35795531-84B8E9E3-B92F-463D-AE1D-F0310BCE0A2EQ35975252-E5BFD640-EDC5-4613-85B0-551B6E8FFDEFQ37446463-63C07D2F-A082-4D40-B9E2-892E5378A50BQ38670339-CE2CEDFB-8688-4B19-84BD-744C35A0071FQ38745085-95DF4051-2E86-4945-B333-B5CC99036988Q38842583-7BC220F8-3D3E-490F-B3DE-5DFF31082BB1Q39131270-0AD7274F-BC5F-47E8-A862-CB19791F3890Q39269469-1A2E3376-C39B-489D-B108-6FE9A526AA3CQ40128575-D55E0C1F-3126-4250-BC8E-B5AC625583DEQ40749335-E853B9A2-4A17-4459-9728-E2A0BB17BE00Q42632921-D51C4D07-3E2B-478C-AEEC-F713B3724ECCQ44962266-CFB576C5-C62F-4244-9E36-3140F4095B23Q47432516-06DD3BC0-ADAD-4511-A238-C24B2FA14051Q47949016-AEA41649-2AFB-4063-B04B-FB14CF7D0228Q48204722-D37A8C98-B2A7-4DF0-BE7A-6FB7A63302A7Q48611096-2B6211DA-0532-4AE4-B5F5-9F7A35F9FE4FQ51443904-88119C76-CD0B-46CC-9CB0-A80D3F14A7C5Q57468614-22551BEB-9572-4AC3-8BA7-12257C36A532Q57468707-01A915D9-9C30-4563-AE0C-2B406146835BQ57658686-5373D9D3-7875-4BFB-96BC-7C3717AEF2E6Q79379179-6A81B210-2A3C-4B1C-B632-49824409B296Q81624801-AF976DBF-5D59-4F63-B364-5636BD8C98F2Q82984531-DF51AED7-56F7-4A7A-8F3D-2D6E9F4101DBQ87162040-B35A0A94-2E7D-49EA-AAB5-DC0B26952C52Q89453085-70977A54-B3ED-4CE8-9194-9607DD312FCFQ90118839-272F3724-ACF8-4E83-9F88-A836187CAFF2
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Verity Watson
@ast
Verity Watson
@en
Verity Watson
@es
Verity Watson
@nl
type
label
Verity Watson
@ast
Verity Watson
@en
Verity Watson
@es
Verity Watson
@nl
prefLabel
Verity Watson
@ast
Verity Watson
@en
Verity Watson
@es
Verity Watson
@nl
P106
P1153
8161713500
P31
P496
0000-0002-3824-5076